Orthofix International | OFIX - Cost Of Sales


Orthofix International reported $253.61M in Cost of Sales for its fiscal quarter ending in December of 2024.





Cost Of Sales Change Date
AngioDynamics USD 33.15M 208K Feb/2025
AtriCure USD 32.94M 1.72M Sep/2025
Dexcom USD 477.9M 9.6M Sep/2025
EDAP TMS EUR 9.22M 1.36M Jun/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Hologic USD 463.7M 5.1M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 196.2M 700K Sep/2025
Integra LifeSciences USD 195.07M 11.2M Sep/2025
J&J USD 7.97B 689M Dec/2025
Medtronic USD 3.52B 80M Sep/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Orthofix International USD 253.61M 192.05M Dec/2024
Smith & Nephew USD 870M 17M Dec/2025
STAAR Surgical USD 16.86M 5.34M Sep/2025
Stryker USD 2.69B 373M Dec/2025
Surmodics USD 33.03M 24.58M Sep/2024
Tandem Diabetes Care USD 114.96M 138K Sep/2025
Teleflex USD 461.38M 111.57M Sep/2025
Veracyte USD 41.21M 196K Sep/2025
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025